Literature DB >> 14607116

High-density functional display of proteins on bacteriophage lambda.

Amita Gupta1, Masanori Onda, Ira Pastan, Sankar Adhya, Vijay K Chaudhary.   

Abstract

We designed a bacteriophage lambda system to display peptides and proteins fused at the C terminus of the head protein gpD of phage lambda. DNA encoding the foreign peptide/protein was first inserted at the 3' end of a DNA segment encoding gpD under the control of the lac promoter in a plasmid vector (donor plasmid), which also carried lox P(wt) and lox P(511) recombination sequences. Cre-expressing cells were transformed with this plasmid and subsequently infected with a recipient lambda phage that carried a stuffer DNA segment flanked by lox P(wt) and lox P(511) sites. Recombination occurred in vivo at the lox sites and Amp(r) cointegrates were formed. The cointegrates produced recombinant phage that displayed foreign protein fused at the C terminus of gpD. The system was optimised by cloning DNA encoding different length fragments of HIV-1 p24 (amino acid residues 1-72, 1-156 and 1-231) and the display was compared with that obtained with M13 phage. The display on lambda phage was at least 100-fold higher than on M13 phage for all the fragments with no degradation of displayed products. The high-density display on lambda phage was superior to that on M13 phage and resulted in selective enrichment of epitope-bearing clones from gene-fragment libraries. Single-chain antibodies were displayed in functional form on phage lambda, strongly suggesting that correct disulphide bond formation takes place during display. This lambda phage display system, which avoids direct cloning into lambda DNA and in vitro packaging, achieved cloning efficiencies comparable to those obtained with any plasmid system. The high-density display of foreign proteins on bacteriophage lambda should be extremely useful in studying low-affinity protein-protein interactions more efficiently compared to the M13 phage-based system.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14607116     DOI: 10.1016/j.jmb.2003.09.033

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  15 in total

Review 1.  Therapeutic and prophylactic applications of bacteriophage components in modern medicine.

Authors:  Sankar Adhya; Carl R Merril; Biswajit Biswas
Journal:  Cold Spring Harb Perspect Med       Date:  2014-01-01       Impact factor: 6.915

2.  Dense display of HIV-1 envelope spikes on the lambda phage scaffold does not result in the generation of improved antibody responses to HIV-1 Env.

Authors:  Jonelle Mattiacio; Scott Walter; Matt Brewer; William Domm; Alan E Friedman; Stephen Dewhurst
Journal:  Vaccine       Date:  2011-02-18       Impact factor: 3.641

3.  Use of bacteriophage particles displaying influenza virus hemagglutinin for the detection of hemagglutination-inhibition antibodies.

Authors:  William Domm; Matthew Brewer; Steven F Baker; Changyong Feng; Luis Martínez-Sobrido; John Treanor; Stephen Dewhurst
Journal:  J Virol Methods       Date:  2013-12-06       Impact factor: 2.014

Review 4.  Biomedical and Catalytic Opportunities of Virus-Like Particles in Nanotechnology.

Authors:  B Schwarz; M Uchida; T Douglas
Journal:  Adv Virus Res       Date:  2016-11-08       Impact factor: 9.937

5.  Immunogenic display of diverse peptides on virus-like particles of RNA phage MS2.

Authors:  David S Peabody; Brett Manifold-Wheeler; Alexander Medford; Sheldon K Jordan; Jerri do Carmo Caldeira; Bryce Chackerian
Journal:  J Mol Biol       Date:  2008-04-27       Impact factor: 5.469

6.  Symmetry Controlled, Genetic Presentation of Bioactive Proteins on the P22 Virus-like Particle Using an External Decoration Protein.

Authors:  Benjamin Schwarz; Patrick Madden; John Avera; Bridget Gordon; Kyle Larson; Heini M Miettinen; Masaki Uchida; Ben LaFrance; Gautam Basu; Agnieszka Rynda-Apple; Trevor Douglas
Journal:  ACS Nano       Date:  2015-08-18       Impact factor: 15.881

Review 7.  Phage engineering and the evolutionary arms race.

Authors:  Huan Peng; Irene A Chen
Journal:  Curr Opin Biotechnol       Date:  2020-10-23       Impact factor: 9.740

8.  Immunization with M2e-displaying T7 bacteriophage nanoparticles protects against influenza A virus challenge.

Authors:  Hamidreza Hashemi; Somayeh Pouyanfard; Mojgan Bandehpour; Zahra Noroozbabaei; Bahram Kazemi; Xavier Saelens; Talat Mokhtari-Azad
Journal:  PLoS One       Date:  2012-09-24       Impact factor: 3.240

Review 9.  Filamentous bacteriophage fd as an antigen delivery system in vaccination.

Authors:  Antonella Prisco; Piergiuseppe De Berardinis
Journal:  Int J Mol Sci       Date:  2012-04-24       Impact factor: 6.208

10.  A simple method for displaying recalcitrant proteins on the surface of bacteriophage lambda.

Authors:  Christine N Zanghi; Heather A Lankes; Birgit Bradel-Tretheway; Jessica Wegman; Stephen Dewhurst
Journal:  Nucleic Acids Res       Date:  2005-10-13       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.